Characterization of Photoluminescent Polylactone-Based Nanoparticles for Their Applications in Cardiovascular Diseases
Cardiovascular diseases (CVD) affect a large number of the population across the globe and are the leading cause of death worldwide. Nanotechnology-based drug delivery has currently offered novel therapeutic options to treat these diseases, yet combination of both diagnostic and therapeutic abilitie...
Main Authors: | Aneetta E. Kuriakose, Nikhil Pandey, Dingying Shan, Subhash Banerjee, Jian Yang, Kytai T. Nguyen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-11-01
|
Series: | Frontiers in Bioengineering and Biotechnology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fbioe.2019.00353/full |
Similar Items
-
Understanding Sorafenib-Induced Cardiovascular Toxicity: Mechanisms and Treatment Implications
by: Li J, et al.
Published: (2024-03-01) -
Upconversion nanoparticle as a theranostic agent for tumor imaging and therapy
by: Wenkai Fang, et al.
Published: (2016-07-01) -
Prognostic value of vascular remodeling parameters in the development of adverse cardiovascular events in patients with gastric cancer
by: Y. Yu. Kirichenko, et al.
Published: (2022-12-01) -
Characterization of Cardiovascular Alterations Induced by Different Chronic Cisplatin Treatments
by: Esperanza Herradón, et al.
Published: (2017-05-01) -
Multiplex Photoluminescent Silicon Nanoprobe for Diagnostic Bioimaging and Intracellular Analysis
by: Meysam Keshavarz, et al.
Published: (2018-03-01)